Human epididymis secretory protein 4 in idiopathic inflammatory myopathy-associated interstitial lung disease., PMID:40095259
Clinical usefulness of E4-phytohemagglutinin reactive C4-binding protein relative front value in serum for distinguishing between ovarian clear cell adenocarcinoma and endometrioma., PMID:40024277
Biomarkers of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis., PMID:39534599
Cooperative amplification of Prussian blue as a signal indicator and functionalized metal-organic framework-based electrochemical biosensor for an ultrasensitive HE4 assay., PMID:38959719
Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer., PMID:38684875
Autoantibodies, antigen-autoantibody complexes and antigens complement CA125 for early detection of ovarian cancer., PMID:38195887
Cancer Marker Immunosensing through Surface-Enhanced Photoluminescence on Nanostructured Silver Substrates., PMID:38132997
Strategies for Mitigating Commercial Sensor Chip Variability with Experimental Design Controls., PMID:37571487
Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL., PMID:36867090
A Multiple-Array SPRi Biosensor as a Tool for Detection of Gynecological-Oncological Diseases., PMID:36832045
Sensitive Detection of the Human Epididymis Protein-4 (HE4) Ovarian Cancer Biomarker through a Sandwich-Type Immunoassay Method with Laser-Induced Breakdown Spectroscopy., PMID:36762387
Acupuncture-exacerbated pyoderma gangrenosum associated with IgG multiple myeloma., PMID:36608840
Nanobodies for the Early Detection of Ovarian Cancer., PMID:36430166
High-Density Gold Nanoparticles Implanted on Mg/Fe LDH Nanoflowers Assisted Lateral Flow Immuno-Dipstick Assay for Visual Detection of Human Epididymal Protein 4., PMID:36290937
Molecular Biomarkers for the Early Detection of Ovarian Cancer., PMID:36233339
Human epididymis protein 4 (HE4) is a novel biomarker for fibrosis in IgG4-related disease and can predict poor prognosis., PMID:36167476
Development of exploratory algorithms to aid in risk of malignancy prediction of indeterminate pulmonary nodules., PMID:36087784
Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma., PMID:35720032
Association between Rheumatoid Arthritis Disease Activity and Risk of Ovarian Malignancy in Middle-Aged and Elderly Women., PMID:35663045
A novel silk fibroin protein-based fusion system for enhancing the expression of nanobodies in Escherichia coli., PMID:35243528
Targeting and neutralizing human epididymis protein 4 by novel nanobodies to suppress ovarian cancer cells and attenuate cisplatin resistance., PMID:35016970
Fluorescence turn-on immunosensing of HE4 biomarker and ovarian cancer cells based on target-triggered metal-enhanced fluorescence of carbon dots., PMID:34753571
A novel electrochemical sensor based on process-formed laccase-like catalyst to degrade polyhydroquinone for tumor marker., PMID:34517604
HE4 Predicts Progressive Fibrosis and Cardiovascular Events in Patients With Dilated Cardiomyopathy., PMID:34320813
Substrate-Induced Growth of Micro/Nanostructured Zn(OH)F Arrays for Highly Sensitive Microfluidic Fluorescence Assays., PMID:34124881
Identification and characterization of endometrial carcinoma with tumor markers HE4 and CA125 in serum and endometrial tissue samples., PMID:34100573
An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma., PMID:34065481
[Clinical observational study of Nimotuzumab combined with concurrent chemoradiotherapy in the treatment of locally advanced cervical cancer]., PMID:33663192
A high-performance microfluidic detection platform to conduct a novel multiple-biomarker panel for ovarian cancer screening., PMID:35423342
Development of fluorescence/MR dual-modal manganese-nitrogen-doped carbon nanosheets as an efficient contrast agent for targeted ovarian carcinoma imaging., PMID:33256741
An all-graphene quantum dot Förster resonance energy transfer (FRET) probe for ratiometric detection of HE4 ovarian cancer biomarker., PMID:33246782
New Insights in Laboratory Testing for COVID-19 Patients: Looking for the Role and Predictive Value of Human epididymis secretory protein 4 (HE4) and the Innate Immunity of the Oral Cavity and Respiratory Tract., PMID:33147871
Targeted MRI and chemotherapy of ovarian cancer with clinic available nano-drug based nanoprobe., PMID:32771892
Efficacy of bevacizumab combined with nedaplatin in the treatment of ovarian cancer and its effects on tumor markers and immunity of patients., PMID:32277617
Circulating tumor cells in gynaecological malignancies., PMID:32277613
Coupling metal-organic framework nanosphere and nanobody for boosted photoelectrochemical immunoassay of Human Epididymis Protein 4., PMID:32200889
Frequency of BRCA1 and BRCA2 Mutations in Individuals with Breast and Ovarian Cancer in a Chinese Hakka Population Using Next-Generation Sequencing., PMID:32101877
Measuring serum human epididymis secretory protein autoantibody as an early biomarker of lung cancer., PMID:35117419
Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer., PMID:31714597
Recent Advances in Identifying Biomarkers and High-Affinity Aptamers for Gynecologic Cancers Diagnosis and Therapy., PMID:31583159
The use of aggregation-induced emission probe doped silica nanoparticles for the immunoassay of human epididymis protein 4., PMID:31536063
Primary peritoneal serous papillary carcinoma: a case series., PMID:31486887
Ovarian carcinomas express HE4 epitopes independently of each other., PMID:31226514
Sensitive amperometric immunosensor with improved electrocatalytic Au@Pd urchin-shaped nanostructures for human epididymis specific protein 4 antigen detection., PMID:31084737
C60 Mediated Ion Pair Interaction for Label-Free Electrochemical Immunosensing with Nanoporous Anodic Alumina Nanochannels., PMID:30908018
[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa]., PMID:30850152
[Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]., PMID:30733191
Label-free immunosensors based on a novel multi-amplification signal strategy of TiO2-NGO/Au@Pd hetero-nanostructures., PMID:30605806
Neutral Charged Immunosensor Platform for Protein-based Biomarker Analysis with Enhanced Sensitivity., PMID:30582808
Quantitative screening of serum protein biomarkers by reverse phase protein arrays., PMID:30220970
For research use only. Not for human or drug use.
